2010 Annual Meeting | Clinical Epilepsy

Date Monday 04/12/10

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Elson L. So, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to apply classifications of seizures and epilepsy to guide diagnostic evaluation and treatment of these conditions; differentiate the advantages and disadvantages between older and newer antiepileptic drugs; distinguish between epileptic seizures, pseudoseizures, and other mimicking spells; manage seizures and epilepsy before, during, and after pregnancy; decide on the appropriate options for treating antiepileptic drug-resistant epilepsy; recognize distinctive diagnostic and treatment issues in managing seizures in children; determine the proper diagnosis, treatment, and prognosis of acute seizures; and advise patients on their treatment options and prognosis when a period of seizure remission has been achieved.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic, Interactive, Audience Participation

Event Timeline
09:00 AM - 09:45 AM		How to Classify Seizures and Epilepsy Susan T. Herman, MD, FAAN, Susan T. Herman, MD, FAAN
09:45 AM - 10:30 AM		Modern Antiepileptic Drugs: Are They Better? Suzette M. LaRoche, MD, FAAN, Suzette M. LaRoche, MD, FAAN
10:30 AM - 10:45 AM		Break
10:45 AM - 11:30 AM		When Seizures Cluster: Inpatient and Outpatient Interventions Sheryl R. Haut, MD
11:30 AM - 12:15 PM		Epilepsy in Women: Special Considerations
12:15 PM - 12:30 PM		Questions and Answers
12:30 PM - 01:30 PM		Lunch
01:30 PM - 02:15 PM		Things You Need to Know When Managing Seizures in Kids Adam L. Hartman, MD, FAAN, Adam L. Hartman, MD, FAAN
02:15 PM - 03:00 PM		Beyond Antiepileptic Drugs: Surgery, Diet, and Devices Gregory A. Worrell, MD, Gregory A. Worrell, MD
03:00 PM - 03:15 PM		Break
03:15 PM - 04:00 PM		Pseudoseizures and Pseudo-Pseudoseizures: Diagnosis and Management William O. Tatum IV, DO, FAAN, William O. Tatum IV, DO, FAAN
04:00 PM - 04:45 PM		My Patient is Seizure Free: Now What Do I Do? Carl W. Bazil, MD, PhD, FAAN, Carl W. Bazil, MD, PhD, FAAN
04:45 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Susan T. Herman, MD, FAAN	The institution of Dr. Herman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for National Association of Epilepsy Centers. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Herman has received research support from Epilepsy Foundation; Epilepsy Learning Healthcare System. The institution of Dr. Herman has received research support from CREMedical. The institution of Dr. Herman has received research support from NIH/NINDS. The institution of Dr. Herman has received research support from Marinus. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as a Medical Director, Neurodiagnostics Program with Laboure College. Dr. Herman has a non-compensated relationship as a Professional Advisory Board member with Epilepsy Foundation that is relevant to AAN interests or activities.
Suzette M. LaRoche, MD, FAAN	Dr. LaRoche has received intellectual property interests from a discovery or technology relating to health care. Dr. LaRoche has received publishing royalties from a publication relating to health care. Dr. LaRoche has a non-compensated relationship as a President with American Clinical Neurophysiology Society that is relevant to AAN interests or activities.
Sheryl R. Haut, MD	Dr. Haut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nile AI. Dr. Haut has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ventus. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVe.
Adam L. Hartman, MD, FAAN	Dr. Hartman has received personal compensation for serving as an employee of NINDS/NIH.
Gregory A. Worrell, MD	Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
William O. Tatum IV, DO, FAAN	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Carl W. Bazil, MD, PhD, FAAN	Dr. Bazil has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medical Letter . Dr. Bazil has received publishing royalties from a publication relating to health care.
Elson L. So, MD, FAAN	Dr. So has nothing to disclose.